CUIMC-V9817
Phase II
OPEN TO ACCRUAL
Phase 2a/2b Study Emapalumab: A Window of Opportunity in Pediatric Aplastic Anemia
Formerly PRO00052953 MSKCC-23-278 Emapalumab AA
P-HEMONC-CUIMC-23-040
Phase II
OPEN TO ACCRUAL *
Phase 2 Study BRIDGING PRE-TRANSPLANT INFLAMMATORY DAMPENING for PRIMARY IMMUNE REGULATORY DISORDERS (BRIDGE Trial)
Formally PRO00053939 MSKCC-23-040 (BRIDGE)